Navigation Links
AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial

Cetrorelix showed good safety and tolerability profile Reduction of testosterone concentration was maintained above castration level Japanese partner Shionogi initiates Phase 2b trial

QUEBEC CITY, March 22, 2007 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. along with its Japanese partner Shionogi & Co., Ltd. today announced positive results for a Phase 2a trial with cetrorelix in benign prostatic hyperplasia (BPH) initiated in 2005 in Japan. Results showed that cetrorelix, the Company's lead luteinizing hormone-releasing hormone (LHRH) antagonist, was safe and well tolerated at all dosage regimens. Furthermore, Japanese patients responded to cetrorelix with a transient reduction of testosterone concentration in blood, which did not reach or remain at the castration level. Additionally, none of the dosage regimens tested caused a suppression of PSA levels. Finally, data generated with Japanese patients showed that the bioavailability of cetrorelix was similar to that observed in non-Japanese patients.

On the basis of this study, Shionogi initiated a 300-patient phase 2b study to assess primarily the efficacy of cetrorelix in BPH in Japanese patients.

"We are very pleased with these results which further confirm the positive data observed in prior clinical trials in BPH with cetrorelix in non-Asian patients", said Gilles Gagnon, President and CEO of AEterna Zentaris. "Shionogi's decision to initiate a Phase 2b trial in BPH combined with our own ongoing Phase 3 program with cetrorelix in this same indication, allows us to pursue the development of cetrorelix at an international level and represents an opportunity to potentially gain access to large markets worldwide."

Nippon Kayaku, the Company's other Japanese partner, has terminated its agreement with respect to their collaboration with the development of cetrorelix pamoate to focus solely in oncology.

About the Phase 2a trial'"/>




Page: 1 2 3 4

Related medicine technology :

1. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
Post Your Comments:
(Date:4/24/2015)... -- Introduction of new "Elements" ... for radiosurgery/SBRT   The "Elements" strategy ... the workflow for difficult to treat indications in ... comes full circle with the introduction of automated ... enable on-the-fly generation of consistent treatment plans for ...
(Date:4/24/2015)... T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), a ... products and a licensed producer ("LP") to cultivate marijuana ... Canada ) ("MMPR"), is pleased to announce that ... the transaction announced on March 11, 2015 with Medna ... a total of 20,156,790 common shares of T-Bird (45% ...
(Date:4/23/2015)... Lifesciences Corporation (NYSE: EW ), the global leader ... today reported net income for the quarter ended March 31, ... Net income for the same period a year earlier ... non-GAAP net income was $82.1 million, or $0.76 per ... ended March 31, 2015 increased 13.0 percent to $590.3 million ...
Breaking Medicine Technology:Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16
... spinal company continues to focus on unmet needs of the lumbar ... ... disc, MINNEAPOLIS, May 1 CoreSpine Technologies, LLC, an,emerging spinal ... implant procedures to include an application,for minimally invasive fusion., The ...
... predict life-long tendency to inflammation ... related cardiovascular event risk profile, WALTHAM, Mass., May ... announced publication of the results of clinical,studies that support ... The article, titled, "IL1B Gene Promoter Haplotype,Pairs Predict Clinical ...
Cached Medicine Technology:CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts 2Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics' Heart Health Test 2Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics' Heart Health Test 3Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics' Heart Health Test 4Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics' Heart Health Test 5
(Date:4/25/2015)... 2015 The Hon. Ellen Tauscher, Independent ... the following statement following the deadly earthquake in Nepal: ... resulting in the deaths of more than 1,000 people. ... across Nepal, Bangladesh, India and other parts of South ... to the people of Nepal and the families of ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 Carinsurancequotesinfo.com has ... find low cost auto insurance for flatbed ... heavy goods and sometimes other vehicles. They are mainly ... insurance. The newly released blog post explains that by ... for trucks, vans and other commercial vehicles. , It ...
(Date:4/25/2015)... 25, 2015 An expanded and newly ... of successfully welcoming visitors to the Turks and Caicos ... As part of a major construction project occurring in ... redesigned to speed up arrivals. A new exterior ... out of the airport and onto Grace Bay beach! ...
(Date:4/25/2015)... New York (PRWEB) April 25, 2015 The ... Dr. Jerry Blaivas has been chosen by the New York ... his contributions to medicine in the field of Urology. , ... best in his speciality, Genito-Urinary diseases. He was a ... in the field of urology. Not only did he ...
(Date:4/25/2015)... 2015 For thirteen years, the Twin Cities ... education event in the nation! This year, on May 5th, ... US to take DI Day on the road by supporting ... CLU, ChFC, RHU, DIA, CLTC, Chief Executive Officer at Secura ... on the change by stating, "The first Twin Cities DI ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Secura Consultants Takes DI Day On The Road 2
... words today throughout the country are 'Dengue' and ... the bite of an infected// Aedes aegypti female ... states. Dengue is the most common mosquito-borne viral ... administrative machinery is battling with a situation that is threatening ...
... normally used to treat ulcers, was found to prevent ... women in developing countries, according// to a study conducted ... India's Jawaharlal Nehru Medical College, and the National Institutes ... Oct. 8 issue of Lancet, found misoprostol reduced the ...
... pregnant women suffering from malaria was found to be safe ... and at the London School of Hygiene & Tropical Medicine ... the malarial parasite without any serious side effects in the ... only with the drug amodiaquine or in combination with sulphadoxine-pyrimethamine ...
... of bowel cancer is greater among women than among men ... a Sydney study that was carried on 1200 bowel cancer ... likely to die from their disease compared to males. On ... aged 50 and under actually had a better survival rate ...
... of stroke in Perth, Western Australia by 43% over the ... George Institute for International Health at the Annual Scientific Meeting ... ,Stroke affects around 17 million people globally and is ... Nationally, over 53,000 strokes occur each year, of which one ...
... in the HIV/AIDS prevalence rate in Kenya from 6.1% in ... Control Council of Kenya (NACC) released the latest data, according ... 9.6 % whereas in rural areas it is 4.6%.,A variety ... preventing pregnant HIV-positive mothers from passing the virus to their ...
Cached Medicine News:Health News:Dengue and Chikungunya: The Dirge of a Nation 2Health News:Dengue and Chikungunya: The Dirge of a Nation 3Health News:Dengue and Chikungunya: The Dirge of a Nation 4Health News:Ulcer Drug Could Save Lives of Women in Developing Countries 2Health News:New method to treat malaria in pregnant women 2Health News:Increased Risk of Bowel cancer after Menopause 2Health News:Declining Incidence of stroke in Australia 2Health News:Decrease in AIDS prevalence rate in Kenya 2
... Unparalleled Comfort Pick one of our pipettors ... the trigger and ejector positionsright where they should ... are ergonomically designed to help avoid repetitive stress ... Productivity In The Palm Of Your Hand ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
... Ergonomic Design for Unparalleled Comfort Pick ... Notice the balance. Notice the trigger and ejector ... Thats because our pipettors are ergonomically designed to ... hours of pipetting. Productivity In The Palm ...
... The total ergonomic solution and best value ... feather touch action and ultra lightweight design ... tip ejection with long, lever tip ejector ... , Accepts universal tips or for greater ...
Medicine Products: